Leon-Ferre, Roberto A.
Whitaker, Kaitlyn R.
Suman, Vera J.
Hoskin, Tanya
Giridhar, Karthik V.
Moore, Raymond M.
Al-Jarrad, Ahmad
McLaughlin, Sarah A.
Northfelt, Donald W.
Hunt, Katie N.
Conners, Amy Lynn
Moyer, Ann
Carter, Jodi M.
Kalari, Krishna
Weinshilboum, Richard
Wang, Liewei
Ingle, James N.
Knutson, Keith L.
Ansell, Stephen M.
Boughey, Judy C.
Goetz, Matthew P.
Villasboas, Jose C.
Article History
Received: 22 February 2024
Accepted: 22 May 2024
First Online: 10 June 2024
Declarations
:
: The Mayo Clinic Institutional Review Board and appropriate committees approved this study. All patients provided written informed consent.
: Before enrollment in the clinical trial, all patients consented for the treatment of their coded data for the publication of the study results. This publication does not contain identifiable patient data or images.
: RL-F: Dr. Leon-Ferre reports consulting fees paid to Mayo Clinic from Gilead Sciences, Lyell Immunopharma and AstraZeneca, outside of the scope of this work, and personal fees for CME activities from MJH Life Sciences. MPG: Dr. Goetz reports personal fees for CME activities from Research to Practice, Clinical Education Alliance, Medscape, and MJH Life Sciences; personal fees serving as a panelist for a panel discussion from Total Health Conferencing and personal fees for serving as a moderator for Curio Science; consulting fees to Mayo Clinic from ARC Therapeutics, AstraZeneca, Biotheranostics, Blueprint Medicines, Lilly, Novartis, Rna Diagnostics, Sanofi Genzyme, Seattle Genetics, Sermonix, Engage Health Media, Laekna and TerSera Therapeutics/Ampity Health; grant funding to Mayo Clinic from Lilly, Pfizer, Sermonix, Loxo, AstraZeneca and ATOSSA Therapeutics; and travel support from Lilly. JCB: Dr. Boughey reports research support paid to Mayo Clinic from Eli Lilly and SymBioSis, outside of the scope of this work, participation on a DSMB for CairnsSurgical, and personal fees for speaking for PER, PeerView, EndoMag and contributing a chapter to UpToDate. KRW, VJS, TH, KVG, RM, AA-J, JMC, KK, RW, LW, JNI, KLK, SMA, and JCV report no conflicts of interest within the scope of this work.